SEC Filings

8-K
ENVISION HEALTHCARE CORP filed this Form 8-K on 10/31/2017
Entire Document
 
Envision Healthcare Reports 2017 Third Quarter Financial Results
 
Page 12
 
 
October 31, 2017
 
 



Envision Healthcare Corporation
Unaudited Selected Consolidated Financial and Operating Data, continued
(In millions)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
Statement of Cash Flow Data:
2017
 
2016
 
2017
 
2016
Cash flows from operating activities:
 
 
 
 
 
 
 
Net earnings (loss)
$
79.0

 
$
95.6

 
$
(204.2
)
 
$
283.4

Adjustments to reconcile net earnings (loss) to net cash flows provided by operating activities:
 
 
 
 
 
 
 
Depreciation and amortization
112.6

 
31.6

 
324.4

 
90.7

Amortization of deferred loan costs
4.4

 
2.2

 
12.8

 
6.4

Provision for uncollectibles
1,302.2

 
152.3

 
3,813.1

 
359.3

Net (gain) loss on disposals and deconsolidations
3.3

 
(4.1
)
 
8.8

 
(6.7
)
Share-based compensation
11.1

 
6.1

 
40.4

 
21.2

Deferred income taxes
45.4

 
13.6

 
574.7

 
34.6

Equity in earnings of unconsolidated affiliates
(5.1
)
 
(4.4
)
 
(16.0
)
 
(18.4
)
Impairment charges

 

 
0.3

 

Net change in fair value of contingent consideration
0.3

 

 
0.3

 
(2.6
)
Other, net

 
(0.2
)
 

 
(3.9
)
Increases (decreases) in cash and cash equivalents, net of acquisitions and dispositions:
 
 
 
 
 
 
 
Accounts receivable
(1,433.8
)
 
(159.4
)
 
(4,011.7
)
 
(387.7
)
Supplies inventory
0.4

 
(0.3
)
 
(0.3
)
 
(0.7
)
Prepaid and other current assets
4.5

 
7.6

 
(0.6
)
 
(16.1
)
Accounts payable
(0.9
)
 
(2.3
)
 
(7.0
)
 
(5.6
)
Accrued expenses and other liabilities
60.4

 
13.8

 
15.0

 
(14.4
)
Other, net
(1.5
)
 
3.9

 
11.0

 
11.5

Net cash flows provided by operating activities
182.3

 
156.0


561.0


351.0

Cash flows from investing activities:
 
 
 
 
 
 
 
Acquisitions and related expenses, net of cash acquired
(208.7
)
 
(70.6
)
 
(694.4
)
 
(351.7
)
Acquisition of property and equipment
(47.8
)
 
(26.4
)
 
(138.5
)
 
(64.0
)
Increase in cash due to consolidation of previously unconsolidated affiliates

 
31.4

 

 
31.4

Purchases of marketable securities
(2.8
)
 

 
(18.7
)
 
(0.5
)
Maturities of marketable securities
0.2

 
0.3

 
7.2

 
3.0

Other, net
1.0

 
2.2

 
(4.2
)
 
(6.5
)
Net cash flows used in investing activities
(258.1
)
 
(63.1
)

(848.6
)

(388.3
)
Cash flows from financing activities:
 
 
 
 
 
 
 
Proceeds from long-term borrowings
2.9

 
112.9

 
801.2

 
430.0

Repayment on long-term borrowings
(13.7
)
 
(115.5
)
 
(328.0
)
 
(214.3
)
Distributions to noncontrolling interests
(55.3
)
 
(56.5
)
 
(174.3
)
 
(172.1
)
Proceeds from issuance of common stock upon exercise of stock options
0.3

 

 
4.0

 
0.5

Repurchase of common stock
(0.5
)
 
(0.5
)
 
(9.4
)
 
(6.1
)
Financing costs incurred
(0.6
)
 

 
(3.5
)
 

Other, net
(2.6
)
 
(1.3
)
 
(14.7
)
 
(1.3
)
Net cash flows provided by (used in) financing activities
(69.5
)
 
(60.9
)

275.3


36.7

Net increase (decrease) in cash and cash equivalents
(145.3
)
 
32.0


(12.3
)

(0.6
)
Cash and cash equivalents, beginning of period
464.6

 
74.1

 
331.6

 
106.7

Less cash and cash equivalents of held for sale assets, end of period
41.2

 

 
41.2

 

Cash and cash equivalents, end of period
$
278.1

 
$
106.1

 
$
278.1

 
$
106.1


-MORE-